WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Resources > Whitepapers > Rethinking Indicators of Project Success in Healthcare
March 4, 2020
I'm For Real
Enter your details once to access all our information and resources
Well is a health technology and services company with a mission to be the world’s most effective partner in the advancement of individualized health.
whitePaper | May 18, 2022
Post-COVID conditions, also known by such terms as long COVID and post-acute sequelae of COVID-19, have become an issue of growing national concern. Until recently, researchers were limited by the lack of a specific ICD-10 diagnosis code for post-COVID conditions.
whitePaper | August 3, 2022
Stages 1 and 2 of the Meaningful Use guidelines incented healthcare organizations to adopt EHR technology, but they did not offer best practices for how the accumulated patient data should be handled.
whitePaper | March 3, 2023
Hospitals throughout the United States and worldwide have struggled with understaffing for years, with the effects of the COVID-19 pandemic pushing them to their limits.
whitePaper | January 9, 2020
Radiation therapy is one of the most common treatments used to fight cancer in the U.S., with more than half of cancer patients receiving it either alone or in combination with other medical interventions.1 With the traditional approach to radiation therapy, the dose and schedule is tailored to the tumor type, location, and stage of growth, but only infrequently updated in light of changes after treatment starts. Experts in adaptive therapy are looking to deliver a more personalized treatment strategy guided by the individual patient’s needs.
whitePaper | May 2, 2022
Medical device cybersecurity is getting more attention than ever before. There are several reasons for this. New regulations, the SBOM initiative, and President's Biden’s executive order and subsequent request from Congress for a 14% increase in budget for supply chain and cybersecurity
whitePaper | June 3, 2022
With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible.
Conference
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE